2/9/2007

New research shows Merck's Arcoxia, a Cox-2 inhibitor for killing pain, has fewer side effects than the NSAID diclofenac, with which it was compared. The study said Arcoxia caused fewer stomach disorders and complications than diclofenac.

Full Story:
Reuters

Related Summaries